The reality of drug shortages - The case of the injectable agent propofol

New England Journal of Medicine

Volumn 363, Issue 9, 2010, Pages 806-807

  Jensen, Valerie ^a   Rappaport, Bob A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; CISATRACURIUM; EPHEDRINE; METOCLOPRAMIDE; PROCHLORPERAZINE; PROPOFOL; SUXAMETHONIUM; VECURONIUM;

DRUG CONTROL; DRUG MANUFACTURE; DRUG MARKETING; DRUG UTILIZATION; FOOD AND DRUG ADMINISTRATION; HEALTH CARE SYSTEM; HUMAN; MEDICAL PRACTICE; MICROBIAL CONTAMINATION; PARTICULATE MATTER; PATIENT CARE; PATIENT SAFETY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 77956027434     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1005849     Document Type: Short Survey

References (5)

1. Steinbrook R. Drug shortages and public health. N Engl J Med 2009;361:1525-7.
2. Hampton T. Experts look for ways to lessen impact of drug shortages and discontinuations. JAMA 2007;298:727-8. (Pubitemid 47263172)
3. Propofol drug label. Rockville, MD.: National Library of Medicine. (Accessed June 9, 2010, at http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id= 12155.)
4. Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic - Nevada, 2007. MMWR Morb Mortal Wkly Rep 2008;57:513-7.
5. Current drug shortages. Silver Spring, MD.: Food and Drug Administration. (Accessed June 2, 2010, at http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ ucm050792.htm.)